Tag: Theradaptive
Theradaptive secures US FDA approval to begin enrolment in Phase I/II...
Theradaptive has gained approval from the US Food and Drug Administration (FDA) for its investigational device exemption (IDE) submission to begin enrolling patients into...
Theradaptive secures breakthrough device designation for spinal fusion implant
Theradaptive has announced that the US Food and Drug Administration (FDA) has granted breakthrough medical device designation for the use of its OsteoAdapt SP...
Theradaptive wins additional FDA breakthrough designation for spinal fusion implant
Theradaptive has announced that the US Food and Drug Administration (FDA) has granted breakthrough medical device designation for its OsteoAdapt SP spinal fusion implant...
Theradaptive’s Osteo-Adapt SP spinal fusion implant granted FDA breakthrough device designation
Theradaptive has announced that the US Food and Drug Administration (FDA) has granted breakthrough medical device designation to its Osteo-Adapt SP Spinal Fusion implant...